Rockwell Medical Q1 net sales $18.9M (-17% YoY); net loss improves to $1.5M

ROCKWELL MEDICAL, INC.

2025-Q1 EPS reported -$0.04 revenue$18,914,000

Net sales fell 17% to $18.9M, driven by largest customer transitioning to another supplier.
Received a one-time non-refundable payment of $0.9M from that customer to ensure supply continuity.
Net loss improved 12% to $1.5M ($0.04 loss per share) vs $1.7M in Q1 2024.
Adjusted EBITDA was -$0.4M; cash and investments $17.3M, down $4.3M from year-end 2024.
Reaffirmed 2025 guidance: net sales $65M-$70M, gross margin 16%-18%, adjusted EBITDA -$0.5M to $0.5M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.